They have no money to do an acquisition unless it's another tiny one like Flaskworks. Even then, does it make sense before approval decision? Honestly, if they found a struggling public biotech company and could do a stock swap into that company and use that as an opportunity to account for all shares it makes sense.
Market Data 
Markets 
